“…Self-assembled lipid based liquid crystalline nanoparticles (LCNP) possessing an internal cubic phase structure, known as cubosomes, have been gathering attention as a drug delivery system as they can be loaded with both lipophilic and hydrophilic drugs and they have potential for on-demand reversible release which offers advantages over more commonly used liposomes. − Amphiphilic lipids such as phytantriol and glycerol monoleate (GMO) can self-assemble in excess water to form thermodynamically stable liquid crystalline phases such as the bicontinuous cubic phase. , Cubosomes can then be formed by the dispersion of the “bulk” cubic liquid crystalline phase, usually with the aid of a polymer stabilizer, such as Pluronic F127 or F108. The internal structure of the particles, and approaches to modification for drug delivery or imaging capabilities by incorporation of other agents such as lipids, phospholipids, or metallic nanoparticles have been well studied, − as has the influence of the stabilizer . The cubosomes often have the same microstructure as the bulk liquid crystalline phases but have a larger surface area and are much less viscous, enabling their potential deployment as injectable drug delivery or imaging systems. − The internal structure of the cubic phase particles makes them particularly interesting as MRI contrast agents, as the bound water behaves very differently to bulk water, providing a boost in relaxivity. , The use of cubosomes as contrast agent enhancers was recently reviewed …”